Will Brackenbury is a Senior Lecturer (equivalent to associate professor) in Biomedical Sciences in the Department of Biology at the University of York. Following a PhD in Cell Physiology in Mustafa Djamgoz’ lab at Imperial College London, and a postdoc in Lori Isom’s lab in the Department of Pharmacology at the University of Michigan, he started his ion channel research laboratory at York in 2011 as a Medical Research Council Fellow. His research centres on understanding the role of voltage-gated sodium channels in regulating breast cancer invasion and metastasis. His team is currently exploring the possibility that VGSC-inhibiting antiepileptic and antiarrhythmic drugs may have value for reducing cancer cell metastasis.